TABLE 1.

Clinical and parasitological data for LCL patients

Patient no.a	Days to development of lesion(s)b	No. of lesions	Location of lesion(s)	Adenopathy	Lymphangitis	No. of parasitesc
Group 1
1	10	3	Upper limbs	Yes	Yes	1-5
2	15	1	Lower limb	No	No	<1
3	21	1	Upper limb	Yes	No	<1
4	21	1	Upper limb	No	No	1-5
5	21	1	Upper limb	No	No	<1
6	21	2	Lower limbs	No	No	<1
7	21	1	Lower limb	No	No	1-5
8	30	1	Upper limb	No	No	<1
9	30	6	Head, upper limbs	No	No	<1
10	30	1	Upper limb	Yes	Yes	<1
Group 2
11	40	1	Upper limb	Yes	No	1-5
12	45	1	Thorax	No	No	<1
13	45	4	Neck, thorax, upper and lower limbs	No	No	<1
14	45	1	Thorax	No	No	<1
15	45	3	Upper and lower limbs	Yes	No	1-5
16	60	6	Lower limbs	Yes	No	1-5
17	60	3	Lower limbs	Yes	Yes	1-5
18	60	1	Upper limb	Yes	No	1-5
19	60	3	Lower limbs	Yes	No	1-5
20	60	3	Head, upper limbs	No	No	1-5
21	60	1	Lower limb	No	No	<1
22	60	1	Upper limb	Yes	Yes	1-5
23	60	1	Lower limb	Yes	Yes	1-5
24	75	2	Upper limbs	Yes	Yes	1-5
25	75	5	Head, upper limbs	No	Yes	<1
26	90	6	Head, upper and lower limbs	No	No	10
27	90	1	Upper limb	Yes	No	<1
28	90	1	Lower limb	Yes	No	1-5
29	90	1	Lower limb	Yes	No	1-5

^aGroup 1, patients who react with IFN-γ production of >100 pg/ml in response to LACK; group 2, patients who react with IFN-γ production of <100 pg/ml in response to LACK.

^bDuration of lesion before patient sought care.

^cNumber of parasites per 50 fields in May-Grünwald- and Giemsa-stained smears.